Loading...
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
The mechanistic target of rapamycin (mTOR) drives several physiologic and pathologic cellular processes and is frequently deregulated in different types of tumors, including glioblastoma (GBM). Despite recent advancements in understanding the molecular mechanisms involved in GBM biology, the surviva...
Na minha lista:
| Udgivet i: | Dis Markers |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6312595/ https://ncbi.nlm.nih.gov/pubmed/30662577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9230479 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|